A retrospective analysis of cisplatin/carboplatin plus paclitaxel in advanced or recurrent cervical cancer
Author:
Affiliation:
1. Department of Gynecological Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China
Publisher
Informa UK Limited
Subject
Obstetrics and Gynaecology
Link
https://www.tandfonline.com/doi/pdf/10.1080/01443615.2017.1416595
Reference26 articles.
1. Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancer
2. Standard treatment in advanced ovarian cancer in 2005: the state of the art
3. Surgical Treatment of Early-Stage Cervical Cancer
4. Global strategies for the treatment of early-stage and advanced cervical cancer
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Real-world outcomes of first-line maintenance therapy for recurrent or metastatic cervical cancer: A multi-center retrospective study;International Immunopharmacology;2024-03
2. Machine learning for genetic prediction of chemotherapy toxicity in cervical cancer;Biomedicine & Pharmacotherapy;2023-05
3. Marine Sulfated Polysaccharide PMGS Synergizes with Paclitaxel in Inhibiting Cervical Cancer In Vitro;Marine Drugs;2023-04-23
4. Fulfilled but worn out: gynecologic oncologists experience high levels of compassion satisfaction and compassion fatigue;European Journal of Gynaecological Oncology;2023
5. Pelvic bones ADC could help to predict severe hematologic toxicity in patients undergoing concurrent chemoradiotherapy for cervical cancer;Magnetic Resonance Imaging;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3